Medical Center of the Institut Pasteur

7 Members

PoxVac22 – Description of the kinetics of the clinical and biological aspects of the persons consulting in the framework of the management of the MONKEYPOX disease

Fabien Taieb (PI)

Sorry, this entry is only available in French.

4 Members

Register of patients with Verneuil’s disease ( Hidradenitis Suppurativa)

Aude Nassif (PI)

Projet REVE- Pasteur : Register of patients with Verneuil’s disease ( Hidradenitis Suppurativa) from the Institut Pasteur Medical Center In Pasteur, there is no large register of HS patients being informative and exhaustive on […]

5 Members

Projet ABCESS2 :A multicentric randomized double-blind phase 3 trial evaluating the efficacy of a targeted antibiotherapy in Hurley stage 2 active Hidradenitis Suppurativa patients versus doxycycline

Maia Delage Toriel (PI)

There is a strong unmet need in HS treatment. The pathophysiology of HS is most likely multifactorial, including genetic, immune and microbiological factors. Specific pathobionts in HS lesions have been identified by our team. […]

4 Members

ROXANE Project : study of Hidradenitis Suppurativa :genetics and microbiological

Maia Delage Toriel (PI)

Le projet ROXANE comporte 3 volets : 1) un volet génétique qui aura pour but d’identifier de nouveaux gènes de l’HS par deux approches – la recherche au sein de cette cohorte de mutations […]

Dat’AIDS cohort: use of data from NADIS® specialty medical records completed in real time during consultations

A large French prospective cohort of HIV-infected patients: the Nadis Cohort. Pugliese P, Cuzin L, Cabié A, Poizot-Martin I, Allavena C, Duvivier C, El Guedj M, de la Tribonnière X, Valantin MA, Dellamonica P; […]

Patients with a particular immunological/virological profile (long-term asymptomatic, spontaneous controllers, post-treatment controllers): ANRS CO21 CODEX cohort including the iVISCONTI study

The main objective of the Codex CO21 ANRS cohort is to study the clinical and immuno-virological evolution and define virus and host parameters associated with the non-progression of infection in asymptomatic HIV-1 patients for […]

Patients managed from the first infection: Cohort ANRS CO6 PRIMO

Initiated in 1996, it has so far included 2,232 patients living with HIV-1 for less than three months. Its main objective is to improve physiopathological knowledge of primary HIV infection. It now makes it […]

2 Members

Research on HIV-2 in France: Cohort ANRS CO5 HIV-2

The main objective of the ANRS CO5 HIV-2 cohort is to study HIV-2 infection, including the progression of HIV-2 infection and its immuno-virological, epidemiological and clinical characteristics, as well as the response to antiretroviral […]

ANRS CO4 FHDH

ANRS CO4 FHDH as part of the Necker – Pasteur active file and also as a Member of the Scientific Council of the GEC (Clinical Epidemiology Group) group that uses FHDH data under the […]